Home
About
Overview
Sharing Data
ORCID
Help
History (64)
Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial.
RNA. CRISPR goes retro.
Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule.
Carbonic Anhydrase V
Editorial: COVID-19 and its impact on SUD treatment.
See All 64 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Editorial: COVID-19 and its impact on SUD treatment.
Friedmann PD, Abraham A, Evans E, Glass J, Ilgen M, Montgomery L. Editorial: COVID-19 and its impact on SUD treatment. J Subst Abuse Treat. 2020 10; 117:108091.
View in:
PubMed
subject areas
Betacoronavirus
Coronavirus Infections
Delivery of Health Care
Humans
Pandemics
Pneumonia, Viral
Substance-Related Disorders
authors with profiles
Peter D Friedmann MD, MPH, DFASAM, FACP
Elizabeth A Evans PhD